News
The importance in assessing genetic features of canine B-cell lymphomas
Dr. Ryan Morin’s laboratory publishes a recent study assessing the genomic features of canine B-cell lymphoma and highlights differences in human B-cell lymphoma.
Genomics study uncovers a novel feature of mantle cell lymphoma biology
In a new study published in the journal Blood, led by GSC Senior Scientist Dr. Ryan Morin, researchers used exome, genome and transcriptome sequencing to characterize MCL tumours and identified a novel feature of MCL biology.
DNA sequencing reveals mechanisms of treatment resistance in patients with diffuse large B cell lymphoma
When treatment with frontline therapeutics fails for patients with diffuse large B cell lymphoma (DLBCL), prognosis is very poor. By sequencing tumour DNA from patients with relapsed disease, researchers have now uncovered genetic mutations that contribute to treatment failure and resistance, paving the way to better treatment strategies.
A genetic explanation for lymphoma patients that can’t be cured by standard treatment
Some patients with non-Hodgkin lymphoma respond poorly to standard treatment. Thanks to DNA sequencing, scientists now know why.
Dr. Ryan Morin receives 2019 American Society of Hematology Scholar Award
One of ASH’s most prestigious award programs, Scholar Awards support fellows and junior faculty dedicated to improving understanding, diagnosis, treatment and prevention of blood disorders. Dr. Morin's lab is the only recipient from Canada this year.